Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program

10 September 2020

Helsinn Group announces AKYNZEO® injection – a new liquid IV solution — now available in the US

20 August 2020

Helsinn Advanced Synthesis opens its largest dedicated Anticancer bay

30 July 2020

3B Future Health Fund announces new investment in iOnctura

14 July 2020

FONDAZIONE IBSA: AL VIA IL BANDO 2020 PER LE 5 BORSE DI STUDIO ANNUALI

25 June 2020

Helsinn Group supports Conquer Cancer, the ASCO Foundation’s COVID Impacts Cancer fund

10 June 2020

Helsinn announces launch of oral formulation of Akynzeo® in China

9 June 2020

Helsinn announces FDA acceptance of IND application for TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities

8 June 2020

Helsinn Group announces FDA approval of a new liquid formulation of AKYNZEO® (fosnetupitant/palonosetron) injection in the United States

2 June 2020

Open Accelerator: the international program for start-ups in Life Science is back with a new Call for Solutions

26 May 2020